Shamburg News · 8-K filed Oct 13, 2026, 9:26 AM EDT
SS Innovations Submits Response to FDA Request for Additional Information on SSi Mantra 510(k)
SSII · SS Innovations International, Inc.
- Other event
- Other
- Materiality: medium
On October 5, 2026, SS Innovations International submitted its response to an FDA request for additional information regarding its 510(k) submission for the SSi Mantra surgical robotic system. The response includes final data from an expanded human clinical and human factors validation study and from a bridging study completed in August 2026 in Bucaramanga, Colombia. The company anticipates the FDA will complete its review in the first quarter of 2027, with the initial indication being cholecystectomy.
Source: SEC EDGAR, Form 8-K, Items 8.01, 9.01, accession 0001213900-26-108792.
Written from the filing by Shamburg Markets. Figures are as reported by the company.